Hair relaxers have been linked to cancer among Black women, litigation says. 'Nobody cares except us'

by Darcel Rockett, Chicago TribuneCredit: Unsplash/CC0 Public DomainLaTonya Shuler, 50, of Indianapolis, had planned to have children. But at age 32, she was diagnosed with uterine cancer. After six w

Updated on: January 04,2024 8

Hair relaxers have been linked to cancer among Black women, litigation says. 'Nobody cares except us'

by Darcel Rockett, Chicago TribuneCredit: Unsplash/CC0 Public DomainLaTonya Shuler, 50, of Indianapolis, had planned to have children. But at age 32, she was diagnosed with uterine cancer. After six w

Updated on:January 04,2024 8

Analysis of Medicine:Metabolic reprogramming in the tumor microenvironment modulates tumor immune response and immunotherapy

Updated on: April 17,2024 0

Analysis of Medicine:Metabolic reprogramming in the tumor microenvironment modulates tumor immune response and immunotherapy

Updated on:April 17,2024 0

Using a machine learning algorithm with cancer methylation signatures to diagnose colorectal cancer

by Bob Yirka , Medical XpressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0A team of researchers affiliated with a large number of institutions in China has used a m

Updated on: December 20,2023 16

Using a machine learning algorithm with cancer methylation signatures to diagnose colorectal cancer

by Bob Yirka , Medical XpressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0A team of researchers affiliated with a large number of institutions in China has used a m

Updated on:December 20,2023 16

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the

Updated on: December 23,2023 16

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the

Updated on:December 23,2023 16

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w

Updated on: October 12,2023 202

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w

Updated on:October 12,2023 202

Is the next big step in cancer therapy personalized vaccines?

byUniversity of California - San DiegoEzra Cohen, MD, UC San Diego Health physician scientist, administered the first-of-its-kind personalized cancer vaccine to Tamara Strauss, while Aaron Mille

Updated on: December 18,2023 19

Is the next big step in cancer therapy personalized vaccines?

byUniversity of California - San DiegoEzra Cohen, MD, UC San Diego Health physician scientist, administered the first-of-its-kind personalized cancer vaccine to Tamara Strauss, while Aaron Mille

Updated on:December 18,2023 19

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Updated on: December 22,2023 22

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Updated on:December 22,2023 22

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp

Updated on: December 19,2023 8

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp

Updated on:December 19,2023 8

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on: December 17,2023 10

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on:December 17,2023 10

Developing a promising new cancer therapy based on natural killer cells

byAlbert Einstein College of MedicineLeft shows the tumor-cell protein PVR binding with the NK-cell receptor KIR2DL5 to prevent NK-cell attack. Right, monoclonal antibody short-circuits tumor ce

Updated on: December 26,2023 9

Developing a promising new cancer therapy based on natural killer cells

byAlbert Einstein College of MedicineLeft shows the tumor-cell protein PVR binding with the NK-cell receptor KIR2DL5 to prevent NK-cell attack. Right, monoclonal antibody short-circuits tumor ce

Updated on:December 26,2023 9

Can gut microbes impact chemotherapy? So far, the answer is 'yes'

by Robin Marks,University of California, San FranciscoIllustration of bacteria in the human gut. Credit: Darryl Leja, National Human Genome Research Institute, National Institutes of HealthBacte

Updated on: December 19,2023 12

Can gut microbes impact chemotherapy? So far, the answer is 'yes'

by Robin Marks,University of California, San FranciscoIllustration of bacteria in the human gut. Credit: Darryl Leja, National Human Genome Research Institute, National Institutes of HealthBacte

Updated on:December 19,2023 12

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

byCancer Research UK| News15 May 2019Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), a

Updated on: December 19,2023 19

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

byCancer Research UK| News15 May 2019Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), a

Updated on:December 19,2023 19